GO:0009185 ribonucleoside diphosphate metabolic process: Nucleotide Metabolism Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009185 describes the chemical reactions and pathways involving ribonucleoside diphosphates, compounds made of a nucleobase linked to ribose esterified with diphosphate.
• Ribonucleoside diphosphates such as ADP and GDP are central intermediates in nucleotide metabolism, energy transfer, and nucleic acid precursor supply.
• Ribonucleotide reductase (RRM1/RRM2) catalyzes the rate-limiting step that converts ribonucleoside diphosphates to deoxyribonucleoside diphosphates, a prerequisite for DNA synthesis.
• ADP and other ribonucleoside diphosphates participate in non-canonical ADP-ribosylation and PARylation reactions that regulate DNA repair and chromatin biology.
• Dysregulation of ribonucleoside diphosphate metabolism is linked to cancer, redox imbalance, and myocardial nucleotide transport defects.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes controlling ribonucleoside diphosphate metabolism.
Description
Ribonucleoside diphosphate metabolic process (GO:0009185) is a biological process ontology term that encompasses the chemical reactions and pathways involving ribonucleoside diphosphates, which are compounds consisting of a nucleobase linked to a ribose sugar esterified with diphosphate on the sugar. These molecules, including ADP, GDP, CDP, and UDP, sit at the crossroads of energy metabolism, nucleic acid precursor biosynthesis, and cellular signaling. Understanding this process is essential because ribonucleoside diphosphates are both substrates and products of enzymes that control DNA synthesis, redox homeostasis, and post-translational modifications. For researchers, GO:0009185 provides a structured framework to annotate genes and pathways that generate, interconvert, or consume ribonucleoside diphosphates. The process is intimately connected to ribonucleotide reductase, which reduces ribonucleoside diphosphates to their deoxy counterparts, a committed step for DNA replication and repair. In addition, ADP-ribose units derived from NAD+ and related diphosphates are transferred to proteins and nucleic acids in non-canonical ADP-ribosylation reactions, expanding the functional repertoire of this metabolic process beyond classical nucleotide biosynthesis. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to describe the definition, mechanism, key genes, disease relevance, and experimental models for GO:0009185. It is designed for molecular biologists, cancer researchers, and CRISPR engineers who need a precise, citable overview of ribonucleoside diphosphate metabolism and its research applications.
ribonucleoside diphosphate metabolic process At A Glance
| GO ID | GO:0009185 |
|---|---|
| GO term | ribonucleoside diphosphate metabolic process |
| Ontology | biological_process |
| Synonym | ribonucleoside diphosphate metabolism |
| Definition | The chemical reactions and pathways involving a ribonucleoside diphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with diphosphate on the sugar. |
| Major function | Production, interconversion, and utilization of ribonucleoside diphosphates such as ADP and GDP in nucleotide metabolism, energy transfer, and DNA precursor synthesis. |
| Key enzymes | Ribonucleotide reductase (RRM1/RRM2), nucleoside diphosphate kinases, and ADP-ribosyltransferases. |
| Related molecules | ADP, GDP, CDP, UDP, deoxyribonucleoside diphosphates, NAD+, and poly(ADP-ribose). |
| Disease relevance | Cancer, redox imbalance, myocardial nucleotide transport defects, and DNA repair disorders. |
What Is GO:0009185?
In our own words, GO:0009185 (ribonucleoside diphosphate metabolic process) refers to the collection of enzymatic reactions and pathways that build, modify, interconvert, and break down ribonucleoside diphosphates. A ribonucleoside diphosphate is a molecule composed of a nitrogenous base attached to a ribose sugar that carries a diphosphate group. This process includes the phosphorylation of ribonucleoside monophosphates to diphosphates, the dephosphorylation of ribonucleoside triphosphates to diphosphates, the reduction of ribonucleoside diphosphates to deoxyribonucleoside diphosphates, and the use of these compounds as substrates in ADP-ribosylation and related modifications.
Why Is ribonucleoside diphosphate metabolic process Important in Cell Biology?
Ribonucleoside diphosphate metabolic process is fundamentally important because it supplies the immediate precursors for DNA synthesis and maintains the balance of cellular energy carriers and signaling molecules. Ribonucleotide reductase converts ribonucleoside diphosphates to deoxyribonucleoside diphosphates, and this step is rate-limiting for DNA replication and repair, making it a long-standing cancer target. Beyond DNA precursors, ribonucleoside diphosphates such as ADP are substrates for ADP-ribosylation reactions that regulate chromatin, DNA damage responses, and gene expression. Disruption of this process has been implicated in lung adenocarcinoma sensitivity to decitabine, purinergic modulation of redox biology, and myocardial nucleotide transport.
• Provides deoxyribonucleoside diphosphates for DNA synthesis through ribonucleotide reductase.
• Maintains cellular energy charge via ADP and GDP pools.
• Supports non-canonical ADP-ribosylation and PARylation that regulate DNA repair and chromatin.
• Influences cancer cell sensitivity to nucleoside analog drugs such as decitabine.
• Connects purinergic signaling to redox homeostasis.
• Is relevant to myocardial nucleotide transport and cardiac physiology.
• Serves as a target space for inhibitors of ribonucleotide reductase in oncology.
• Provides biomarkers and pathway annotations for metabolic and cancer research.
• Enables CRISPR-based causal studies of nucleotide metabolism genes.
• Links nucleotide metabolism to immunotherapy through ENPP1 and related enzymes.
What Happens During ribonucleoside diphosphate metabolic process?
Synthesis and interconversion of ribonucleoside diphosphates
In simple terms: Cells build and swap diphosphate nucleotides to keep the right balance for energy and DNA building blocks.
Ribonucleoside diphosphates are generated through phosphorylation of ribonucleoside monophosphates and dephosphorylation of ribonucleoside triphosphates, and they are interconverted by nucleoside diphosphate kinases. Metal/ADP complexes can promote phosphorylation of ribonucleotides, illustrating how diphosphate nucleotides participate in phosphoryl transfer chemistry. These reactions maintain the pools of ADP, GDP, CDP, and UDP that feed downstream pathways.
Reduction to deoxyribonucleoside diphosphates
In simple terms: A key enzyme trims oxygen off the sugar to make the deoxy versions needed for DNA.
Ribonucleotide reductase catalyzes the reduction of ribonucleoside diphosphates to deoxyribonucleoside diphosphates, a committed and rate-limiting step for DNA synthesis. This enzyme is a validated cancer target, and inhibitors have been developed to block deoxyribonucleotide production. The reaction couples nucleotide metabolism to cell cycle progression and DNA repair.
ADP-ribosylation and PARylation
In simple terms: Cells attach ADP-ribose units to proteins and DNA as a reversible modification.
Non-canonical ADP-ribosylation uses ADP-ribose derived from NAD+ to modify proteins and nucleic acids, expanding the roles of ribonucleoside diphosphate metabolism beyond biosynthesis. Mammalian N1-adenosine PARylation is a reversible DNA modification, showing that ADP-ribose units can be covalently linked to DNA bases. These modifications influence DNA repair, transcription, and chromatin dynamics.
Transport and compartmentalization
In simple terms: Nucleotides must move between cellular compartments to be used.
Myocardial nucleotide transport studies describe how ribonucleoside diphosphates and related nucleotides are moved across membranes in cardiac tissue. Compartmentalization ensures that diphosphate nucleotides are available where they are needed for energy transfer and nucleic acid metabolism. Transport defects can contribute to metabolic stress in the heart.
Redox and purinergic crosstalk
In simple terms: Nucleotide diphosphates talk to redox systems to keep cells healthy.
Purinergic signaling modulates redox biology, linking ADP and related nucleotides to oxidative stress responses. This crosstalk helps cells adapt to metabolic and oxidative challenges. It also connects ribonucleoside diphosphate metabolism to inflammation and immune regulation.
Key Genes Involved in GO:0009185 ribonucleoside diphosphate metabolic process
The following genes encode enzymes and transporters that directly participate in or regulate ribonucleoside diphosphate metabolic process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RRM1 | Large subunit of ribonucleotide reductase; catalyzes reduction of ribonucleoside diphosphates | Cancer target; RRM1 inhibition sensitizes lung adenocarcinoma to decitabine |
| RRM2 | Small subunit of ribonucleotide reductase; essential for catalytic activity | Target for inhibitors in oncology |
| NME1 | Nucleoside diphosphate kinase; interconverts ribonucleoside diphosphates and triphosphates | Metastasis suppressor and nucleotide pool regulator |
| NME2 | Nucleoside diphosphate kinase; maintains nucleotide pools | Studied in cancer and metabolic signaling |
| ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase; hydrolyzes nucleotides including ADP | Cancer immunotherapy target |
| PARP1 | Poly(ADP-ribose) polymerase; uses NAD+ to add ADP-ribose to proteins | DNA repair and PARylation research |
| PARP2 | Poly(ADP-ribose) polymerase; participates in ADP-ribosylation | Chromatin and DNA damage studies |
| NADSYN1 | NAD+ synthetase; supplies NAD+ for ADP-ribosylation | Metabolic and redox research |
| NMNAT1 | Nicotinamide mononucleotide adenylyltransferase; NAD+ biosynthesis | Links NAD+ to ADP-ribose metabolism |
| AK1 | Adenylate kinase; interconverts adenine nucleotides including ADP | Energy metabolism studies |
| AK2 | Adenylate kinase; mitochondrial nucleotide homeostasis | Mitochondrial metabolism research |
| ENTPD1 | Ectonucleoside triphosphate diphosphohydrolase; generates ADP from ATP | Purinergic signaling and redox biology |
| ENTPD2 | Ectonucleoside triphosphate diphosphohydrolase; regulates extracellular nucleotide levels | Purinergic signaling research |
| ADK | Adenosine kinase; adenosine metabolism linked to ADP pools | Redox and purinergic studies |
| NT5E | Ecto-5'-nucleotidase; converts AMP to adenosine | Purinergic signaling and immune regulation |
| CMPK1 | Cytidine monophosphate kinase; phosphorylates CMP to CDP | Pyrimidine nucleotide metabolism |
| UMPK | Uridine monophosphate kinase; phosphorylates UMP to UDP | Pyrimidine nucleotide metabolism |
| PRPS1 | Phosphoribosyl pyrophosphate synthetase; supplies PRPP for nucleotide synthesis | Nucleotide biosynthesis research |
How Is ribonucleoside diphosphate metabolic process Regulated?
Ribonucleoside diphosphate metabolic process is regulated at multiple levels. Ribonucleotide reductase activity is controlled by allosteric regulation and subunit expression to balance deoxyribonucleotide pools. Purinergic signaling modulates redox biology, providing feedback between nucleotide levels and oxidative stress. ADP-ribosylation reactions are dynamically reversed and regulated by enzymes that consume NAD+, linking this process to cellular energy status. In the heart, nucleotide transport mechanisms regulate the availability of diphosphate nucleotides.
ribonucleoside diphosphate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RRM1 | Lung adenocarcinoma and chemotherapy sensitivity | RRM1 knockout or point-mutation cell lines treated with decitabine |
| RRM2 | Cancer proliferation and DNA synthesis | RRM2 overexpression and knockout models for inhibitor testing |
| ENPP1 | Cancer immunotherapy and immune evasion | ENPP1 knockout tumor models and immune co-culture |
| PARP1 | DNA repair deficiency and genomic instability | PARP1 knockout or catalytic-dead knock-in cells |
| AK1 | Cardiac nucleotide transport and energy metabolism | AK1 knockout cardiomyocyte models |
Cancer and chemotherapy response
RRM1 inhibition sensitizes lung adenocarcinoma to decitabine treatment, demonstrating that ribonucleoside diphosphate metabolism modulates chemotherapeutic efficacy. Ribonucleotide reductase is a validated cancer target, and inhibitors have been developed to block deoxyribonucleotide synthesis in tumors. ENPP1 targeting for cancer immunotherapy further links nucleotide metabolism to immune evasion and treatment response.
Redox imbalance and inflammation
Purinergic signaling modulates redox biology, and dysregulation of ADP and related nucleotides can contribute to oxidative stress and inflammation. ADP-ribosylation and PARylation are reversible modifications that influence DNA repair and chromatin, and their perturbation is associated with genomic instability.
Cardiovascular nucleotide transport defects
Myocardial nucleotide transport is essential for cardiac energy metabolism, and defects in nucleotide handling can impair heart function. Understanding ribonucleoside diphosphate metabolism in the heart may inform therapeutic strategies for cardiac disease.
From ribonucleoside diphosphate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is RRM1 required for decitabine sensitivity? | RRM1 knockout lung adenocarcinoma cell line |
| Does a catalytic mutation in RRM2 alter deoxyribonucleotide pools? | RRM2 point-mutation knock-in cells |
| Can ENPP1 loss enhance antitumor immunity? | ENPP1 knockout syngeneic tumor model |
| How does PARP1 catalytic activity affect PARylation? | PARP1 catalytic-dead knock-in cells |
| Does AK1 regulate cardiac nucleotide transport? | AK1 knockout cardiomyocytes |
| Can overexpression of NME1 alter nucleotide pools? | NME1 overexpression cell lines |
How to Study the ribonucleoside diphosphate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of ADP, GDP, CDP, UDP and related nucleotides | Quantifying ribonucleoside diphosphate pools |
| Ribonucleotide reductase activity assay | Conversion of ribonucleoside diphosphates to deoxyribonucleoside diphosphates | Testing RRM1/RRM2 inhibitors |
| ADP-ribosylation immunoblot | Protein ADP-ribose modifications | DNA damage and PARP studies |
| CRISPR knockout screen | Gene fitness and drug sensitivity | Identifying pathway dependencies |
| RNA-seq | Transcriptional changes in nucleotide metabolism genes | Pathway expression profiling |
| Proteomics | Protein abundance and modifications | Mapping ADP-ribosylated proteins |
| Nucleotide transport assays | Membrane transport of nucleotides | Cardiac and metabolic studies |
| Redox assays | Oxidative stress markers | Purinergic signaling research |
Metabolomics and nucleotide quantification
Liquid chromatography-mass spectrometry (LC-MS) can quantify ribonucleoside diphosphates such as ADP and GDP in cell extracts, providing direct readouts of GO:0009185 activity. Stable isotope tracing can follow flux through nucleotide metabolic pathways.
Enzymatic assays for ribonucleotide reductase
Ribonucleotide reductase activity assays measure conversion of ribonucleoside diphosphates to deoxyribonucleoside diphosphates, enabling evaluation of inhibitors and genetic perturbations. These assays are standard in cancer metabolism research.
ADP-ribosylation and PARylation detection
Antibodies and mass spectrometry can detect ADP-ribose modifications on proteins and DNA, linking GO:0009185 to chromatin biology. Reversibility can be assessed by treating samples with ADP-ribosylhydrolases.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for ribonucleoside diphosphate metabolism and drug sensitivity. Pooled screens coupled with sequencing reveal fitness genes in this pathway.
How CRISPR Can Be Used to Study GO:0009185 ribonucleoside diphosphate metabolic process
Knockout
CRISPR knockout of RRM1 or RRM2 can abolish ribonucleotide reductase activity, reducing deoxyribonucleoside diphosphate production and sensitizing cancer cells to nucleoside analogs. Knockout of ENPP1 can enhance antitumor immunity in preclinical models. Knockout of PARP1 disrupts ADP-ribosylation and DNA repair.
Point Mutation
Point mutations in catalytic residues of RRM2 or PARP1 can separate enzymatic activity from scaffolding functions, enabling precise structure-function studies of ribonucleoside diphosphate metabolism. Such models help determine whether catalytic activity is required for drug sensitivity.
Knock-in
Knock-in of tagged or mutant alleles, such as epitope-tagged RRM1 or catalytically dead PARP1, allows tracking of protein localization and activity in live cells. Knock-in models can also introduce disease-associated variants to test their impact on nucleotide metabolism.
Overexpression
Overexpression of NME1, NME2, or RRM1 can elevate ribonucleoside diphosphate metabolic flux and alter nucleotide pools, providing gain-of-function models for pathway analysis. Overexpression of ENPP1 can modulate extracellular nucleotide levels and immune signaling.
How EDITGENE Supports ribonucleoside diphosphate metabolic process Research
Researchers studying ribonucleoside diphosphate metabolic process-related genes often need to determine whether a candidate gene is causally involved in nucleotide pool regulation, drug sensitivity, or disease phenotypes. Rigorous causal inference requires well-controlled genetic models that isolate the gene of interest from compensatory pathways. EDITGENE provides end-to-end CRISPR services to generate such models efficiently and reproducibly.
Contact EDITGENE today to design your custom CRISPR model for ribonucleoside diphosphate metabolic process research.
Frequently Asked Questions About ribonucleoside diphosphate metabolic process
What is GO:0009185 ribonucleoside diphosphate metabolic process?
GO:0009185 is a biological process ontology term describing the chemical reactions and pathways involving ribonucleoside diphosphates, which are nucleobase-ribose-diphosphate compounds such as ADP and GDP.
What genes are involved in ribonucleoside diphosphate metabolic process?
Key genes include RRM1, RRM2, NME1, NME2, ENPP1, PARP1, PARP2, and AK1, which synthesize, interconvert, or utilize ribonucleoside diphosphates.
Why is ribonucleoside diphosphate metabolism important for cancer?
Ribonucleotide reductase converts ribonucleoside diphosphates to deoxyribonucleoside diphosphates for DNA synthesis, and its inhibition sensitizes tumors to drugs like decitabine.
How does ADP-ribosylation relate to ribonucleoside diphosphate metabolism?
ADP-ribosylation uses ADP-ribose units derived from NAD+ to modify proteins and DNA, linking ribonucleoside diphosphate metabolism to DNA repair and chromatin regulation.
What diseases are associated with defects in ribonucleoside diphosphate metabolism?
Dysregulation has been linked to lung adenocarcinoma drug sensitivity, redox imbalance, and myocardial nucleotide transport defects.
What experimental models are used to study GO:0009185?
CRISPR knockout, point-mutation, knock-in, and overexpression cell models, combined with metabolomics and enzymatic assays, are commonly used.
How can I measure ribonucleoside diphosphate levels in cells?
LC-MS metabolomics can quantify ADP, GDP, CDP, and UDP pools, while enzymatic assays measure ribonucleotide reductase activity.
What is the role of RRM1 in ribonucleoside diphosphate metabolism?
RRM1 is the large subunit of ribonucleotide reductase and catalyzes the reduction of ribonucleoside diphosphates to deoxyribonucleoside diphosphates.
Can CRISPR screens identify regulators of ribonucleoside diphosphate metabolism?
Yes, genome-wide CRISPR knockout screens can identify genes required for nucleotide metabolism and drug sensitivity.
How does purinergic signaling connect to ribonucleoside diphosphate metabolism?
Purinergic signaling modulates redox biology and uses nucleotides such as ADP as ligands, linking extracellular nucleotide metabolism to oxidative stress responses.
Conclusion
GO:0009185 ribonucleoside diphosphate metabolic process is a central node in nucleotide metabolism, connecting energy transfer, DNA precursor synthesis, and ADP-ribosylation-dependent regulation. Its dysregulation has been implicated in cancer drug sensitivity, redox imbalance, and cardiac nucleotide transport defects. CRISPR-based models provide powerful tools to dissect the causal roles of genes such as RRM1, RRM2, ENPP1, and PARP1 in this pathway. By combining precise genome editing with metabolomics, proteomics, and functional screens, researchers can map the regulatory architecture of ribonucleoside diphosphate metabolism and identify new therapeutic opportunities.
References
- 1. Jiang N et al.. 2026. RRM1 inhibition sensitizes lung adenocarcinoma to decitabine treatment.. Cell Death Dis 17(1) PMID: 41748545
- 2. Savio LEB et al.. 2021. Purinergic signaling in the modulation of redox biology.. Redox Biol 47:102137 PMID: 34563872
- 3. Werner E et al.. 2023. Metal/ADP Complexes Promote Phosphorylation of Ribonucleotides.. J Am Chem Soc 145(39):21630-21637 PMID: 37750669
- 4. Huff SE et al.. 2022. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present.. Biomolecules 12(6) PMID: 35740940
- 5. Huang R et al.. 2024. Targeting ENPP1 for cancer immunotherapy: Killing two birds with one stone.. Biochem Pharmacol 220:116006 PMID: 38142838
- 6. Musheev MU et al.. 2022. Mammalian N1-adenosine PARylation is a reversible DNA modification.. Nat Commun 13(1):6138 PMID: 36253381
- 7. Schuller M et al.. 2022. Beyond protein modification: the rise of non-canonical ADP-ribosylation.. Biochem J 479(4):463-477 PMID: 35175282
- 8. Rovetto MJ. 1985. Myocardial nucleotide transport.. Annu Rev Physiol 47:605-16 PMID: 2986540
